Chanakya Kodishala _top_ Jun 2026

By embarking on this journey of discovery, we hope to rekindle the spirit of Chanakya Kodishala, inspiring a new generation of scholars, thinkers, and leaders to strive for excellence, to seek wisdom, and to make a positive impact on the world.

Kodishala's Mayo Clinic publications , explore his , or format it specifically for a medical biography website ?

Contributed to studies focused on COVID-19 risk factors in systemic lupus erythematosus (SLE) patients, contributing to literature on immunosuppression and infectious diseases.

In recent years, there has been a renewed interest in reviving the spirit of Chanakya Kodishala. Efforts have been made to recreate the institution in a modern avatar, with a focus on interdisciplinary research, academic excellence, and community engagement. These initiatives aim to rekindle the flame of intellectual curiosity and critical thinking that once burned brightly at Chanakya Kodishala. Chanakya Kodishala

One of his major focus areas involves analyzing how systemic inflammation affects the brain over time. Through long-term population-based cohort studies, Dr. Kodishala and his co-researchers at the Mayo Clinic have unraveled how rheumatoid arthritis (RA) correlates with Alzheimer's disease and related dementias (AD/ADRD).

Future Directions in Rheumatology

While at St. John's Medical College Hospital, Dr. Kodishala collaborated on vital clinical studies tracking multi-center data in India. Published in reputable international journals, these longitudinal studies investigated the risk factors associated with COVID-19 in SLE patients , helping global clinicians optimize the administration of immunosuppressants during periods of viral crisis. Professional Contributions and Impact By embarking on this journey of discovery, we

Strong statistical associations have been noted between baseline anxiety, depression, and subsequent neurodegeneration in autoimmune cohorts. Global Contributions to Autoimmune and Viral Interaction

Dr. Kodishala built a robust medical foundation in India through a series of competitive academic achievements:

Chanakya Kodishala is more than a name on a movie poster’s credit roll. He is a case study in how to turn fandom into a profession. In an era where attention is the most expensive currency, he acts as the chief economist, spending that currency wisely to create cultural moments. In recent years, there has been a renewed

His journey, moving from a top Indian medical school to one of the world’s leading research institutions in the United States, is a testament to his dedication and skill. By focusing on data-driven insights from large population-based cohort studies, he is contributing to a future where treatment for autoimmune diseases is not just about managing pain and inflammation, but also about preserving cognitive function and overall life trajectory.

Based on your background as a Rheumatology Research Fellow at Mayo Clinic and your work on the connection between Rheumatoid Arthritis (RA) and cognitive health